US Stock MarketDetailed Quotes

SXTP 60 Degrees Pharmaceuticals

Watchlist
  • 1.010
  • -0.070-6.48%
Close Dec 4 16:00 ET
  • 1.080
  • +0.070+6.93%
Post 18:57 ET
2.32MMarket Cap-313P/E (TTM)

60 Degrees Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

60 Degrees Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 300.000K--
--2024/Q4-- / 234.000K--
--2024/Q3135.290K / 242.000K--
--2024/Q2124.970K / 211.500K--
--2024/Q1116.460K / 150.000K--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 300.000K--
--2024/Q4-- / 234.000K--
--2024/Q3135.290K / 242.000K--
--2024/Q2124.970K / 211.500K--
--2024/Q1116.460K / 150.000K--

Unlock Free Earnings Estimates

60 Degrees Pharmaceuticals Earnings Reports

  • 10-Q: Q3 2024 Earnings Report

    Nov 14 13:48 ET

  • 10-Q: Q2 2024 Earnings Report

    Aug 14 10:34 ET

  • 10-Q: Q1 2024 Earnings Report

    May 15 12:00 ET

  • 60 Degrees Pharmaceuticals | 10-K: FY2023 Annual Report

    Apr 1 14:37 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Dec 3, 2024

    Buy

    • Buy

      50.00%

    • Hold

      50.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg

    No Data